Showing 1261-1270 of 8881 results for "".
FDA Approves Rosacea Treatment Emrosi
https://practicaldermatology.com/series/dermwire-tv/fda-approves-rosacea-treatment-emrosi/29207/In this week's DermwireTV, the FDA approves a first-of-its-kind treatment for rosacea in adults; two companies with approved atopic dermatitis products provide new long-term efficacy and safety data; and Andrew Mastro discusses how to recognize physician burnout.Skin-vincible: A Children's Book for Living with Ichthyosis
https://practicaldermatology.com/topics/rare-disease/skin-vincible-a-childrens-book-for-living-with-ichthyosis/20260/Drs. Andrea Rustad, a graduate of the Northwestern University Feinberg School of Medicine and incoming dermatology resident at the University of Wisconsin, and Amy Paller, chair of the department of dermatology at the Northwestern Feinberg School of Medicine in Chicago, talk with Practical DermatoloInnovative Techniques for Forehead Wrinkles, Acne Laser Treatment, and More
https://practicaldermatology.com/conferences/maui-derm-2024/innovative-techniques-for-forehead-wrinkles-acne-laser-treatment-and-more/20250/Valerie D. Callender, MD, discusses the 3 cases she presented at Maui Derm 2024: filling in deeply etched forehead wrinkles with a resilient hyaluronic acid filler, treating acne with the 1726 nanometer laser, and treating melasma with a triple-combo procedure that includes maintenance therapy.Factor in Patient Satisfaction Matrix for Best Results
https://practicaldermatology.com/conferences/maui-derm-2024/factor-in-patient-satisfaction-matrix-for-best-results/20249/Chief Medical Editor Neil Bhatia, MD speaks with Maui Derm presenter and educator William P. Werschler, MD about cosmetic updates, including his “patient satisfaction matrix” that helps doctors and patients align on expectations of the outcomes of procedures.Pigmentation: Melasma vs. Postinflammatory Hyperpigmentation
https://practicaldermatology.com/conferences/maui-derm-2024/pigmentation-melasma-vs-hyperpigmentation-vitiligo-treatments-and-full-spectrum-photo-protection/20247/Chief Medical Editor Neal Bhatia, MD and Pearl Grimes, MD, discuss Dr. Grimes’ presentations on pigmentation, including the difference between melasma and postinflammatory hyperpigmentation, and the importance of photo-protection in darker skin types.Exciting Developments in Treating Pediatric Dermatology
https://practicaldermatology.com/conferences/maui-derm-2024/exciting-developments-in-treating-pediatric-dermatology/20246/Chief Medical Editor Neal Bhatia, MD and Lawrence Eichenfield, MD, discuss the range of therapies currently approved or in the pipeline for atopic dermatitis, pruritus, pediatric acne--and the importance of messaging on TikTok.“No Drug is 100 Percent.”
https://practicaldermatology.com/conferences/maui-derm-2024/no-drug-is-100-percent/20242/Jason Hawkes, MD and Chief Medical Editor Neal Bhatia, MD discuss how the current array of options for patients of chronic spontaneous urticaria (CSU) expand treatment options for hives beyond antihistamines.Welcome to the Decade of Eczema
https://practicaldermatology.com/topics/atopic-dermatitis/welcome-to-the-decade-of-eczema/20221/October is Eczema Awareness Month. Peter Lio, MD, discusses the wealth of available treatments for eczema and shares his excitement about the pipeline as part of the National Eczema Association’s new #OneThingAboutEczema campaign.Is Your Sunscreen Safe?
https://practicaldermatology.com/conferences/scale-2023/is-your-sunscreen-safe/20187/Practical Dermatology magazine's newest editorial advisory board member Christopher Bunick, MD, PhD, shares advice on how to choose benzene-free sunscreens and offers tips on making smarter choices about sun protection.Changing Approaches to Diagnosis and Research: DermTech's Contributions
https://practicaldermatology.com/topics/skin-cancer-photoprotection/changing-approaches-to-diagnosis-and-research-dermtechs-contributions/20137/John Dobak, MD, President/CEO of DermTech discusses the addition of the company's melanoma test to the National Comprehensive Cancer Network guidelines. He talks about the future of clinical trials, especially the role of genomics for identifying trial participants and allowing more precise analysis